Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
18 December 2019
Closing Date:
21 January 2020
Location(s):
PL812 Chełmsko-zamojski (PL Poland/POLSKA)
Description:
Purchase and successive supplies of reimbursed drugs covered by the drug program: 1. treatment of chronic hepatitis C with noninterferon therapy, 2. treatment of multiple sclerosis

The subject of the order is the purchase and successive delivery of reimbursed drugs covered by the drug program:

1) treatment of chronic hepatitis C with noninterferon therapy,

2) treatment of multiple sclerosis.


Part 1

Interferonum beta-1a solutions to shake


Part of the 10th

Dimethyl fumarate capsule hard

Dimethyl fumarate capsule hard


Part 2

Teriflunomidum film-coated tablets 0.014 g


Part 3

Interferon beta-1b 0.3 mg - 9.6 million IU + solution for solution to shake


Part 4

Sofosbuvirum, velpatasvirum film-coated tablets


Part of the 5th

Glecaprevirum, pibrentasvirum coated tablets


Part of the 6th

Peginterferon beta-1a solution to shake

Peginterferon beta-1a solution for injection


Part of the 7th

Elbasvir, grazoprevir film-coated tablets

Ribavirinum hard capsules


Part of the 8th

Interferon beta-1a x 4 cartridges inj. Sc


Part of the 9th

Glatirameri acetas solution for injection in ampoules

Download full details as .pdf
The Buyer:
Samodzielny Publiczny Wojewódzki Szpital Specjalistyczny
CPV Code(s):
33600000 - Pharmaceutical products